Neoadjuvant Immunotherapy in Gastroesophageal Cancer: A Promising Early Signal?
J Clin Oncol
.
2024 Feb 1;42(4):373-377.
doi: 10.1200/JCO.23.01982.
Epub 2023 Nov 14.
Authors
Mojun Zhu
1
,
Harry H Yoon
1
Affiliation
1
Department of Oncology, Mayo Clinic, Rochester, MN.
PMID:
37963321
PMCID:
PMC10824372
(available on
2025-02-01
)
DOI:
10.1200/JCO.23.01982
No abstract available
Publication types
Editorial
MeSH terms
Esophageal Neoplasms* / drug therapy
Humans
Immunotherapy
Neoadjuvant Therapy
Stomach Neoplasms* / drug therapy
Grants and funding
R01 CA248147/CA/NCI NIH HHS/United States